EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Pro-Opiomelanocortin and Melanocortin Receptor 3 and 4 Mutations in Genetic Obesity

Tulin Yanik iD, Seyda Tugce Durhan iD

Biomolecules · 01.02.2025 · 15 (2) · 209

DOI: 10.3390/biom15020209 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 01.02.2025. Verfasst von Tulin Yanik und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, Middle East Technical University, Ankara 06800, Türkiye. Hauptthemen laut MEDLINE: Pro-Opiomelanocortin, Receptor, Melanocortin, Type 4, Obesity, Mutation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Scientific and Technological Research Council of Turkey (TUBITAK), Middle East Technical University (METU), YOK 100/2000.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Genetic obesity results from loss-of-function mutations, including those affecting the leptin–melanocortin system, which regulates body weight. Pro-opiomelanocortin (POMC)-derived neurohormones act as ligands for melanocortin receptors (MCRs), regulating the leptin–melanocortin pathway through protein–protein interactions. Loss-of-function mutations in the genes encoding POMC, MC3R, and MC4R can lead to the dysregulation of energy expenditure and feeding balance, early-onset obesity, and developmental dysregulation. Recent studies have identified new genetic regulatory mechanisms and potential biomarker regions for the POMC gene and MC4R secondary messenger pathway associated with obesity. Recent advances in crystal structure studies have enhanced our understanding of the protein interactions in this pathway. This narrative review focuses on recent developments in two key areas related to POMC regulation and the leptin–melanocortin pathway: (1) genetic variations in and functions of POMC, and (2) MC3R and MC4R variants that lead to genetic obesity in humans. Understanding these novel mutations in POMC and MC4R/MC3R, as well as their structural and intracellular mechanisms, may help identify strategies for the treatment and diagnosis of obesity, particularly childhood obesity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pro-OpiomelanocortinReceptor, Melanocortin, Type 4ObesityMutationReceptor, Melanocortin, Type 3HumansLeptinAnimals

Stichwörter der Autor:innen

genetic obesitymelanocortin receptorspro-opiomelanocortin

Substanzen

Pro-OpiomelanocortinReceptor, Melanocortin, Type 4Receptor, Melanocortin, Type 3MC4R protein, humanLeptinMC3R protein, human

Autor:innen und Institutionen

  • Department of Biological Sciences, Middle East Technical University, Ankara 06800, Türkiye.
  • Department of Biochemistry, Middle East Technical University, Ankara 06800, Türkiye.

ORCID-Profile: Tulin Yanik, Seyda Tugce Durhan

Förderung

  • Scientific and Technological Research Council of Turkey (TUBITAK)
  • Middle East Technical University (METU)
  • YOK 100/2000
  • TUBITAK BİDEB 2211-A

Zitieren

APA

Yanik, T., & Durhan, S. T. (2025). Pro-Opiomelanocortin and Melanocortin Receptor 3 and 4 Mutations in Genetic Obesity. Biomolecules, 15(2), 209. https://doi.org/10.3390/biom15020209

Vancouver

Yanik T, Durhan ST. Pro-Opiomelanocortin and Melanocortin Receptor 3 and 4 Mutations in Genetic Obesity. Biomolecules. 2025;15(2):209. doi:10.3390/biom15020209

BibTeX
@article{Yanik2025,
  author = {Yanik, Tulin and Durhan, Seyda Tugce},
  title = {Pro-Opiomelanocortin and Melanocortin Receptor 3 and 4 Mutations in Genetic Obesity},
  journal = {Biomolecules},
  year = {2025},
  volume = {15},
  number = {2},
  pages = {209},
  doi = {10.3390/biom15020209}
}
Kostenlos starten →